7-days of FREE Audio papers, translation & more with Prime
7-days of FREE Prime access
7-days of FREE Audio papers, translation & more with Prime
7-days of FREE Prime access
https://doi.org/10.1096/fasebj.23.1_supplement.926.2
Copy DOIJournal: The FASEB Journal | Publication Date: Apr 1, 2009 |
Background and PurposeSubstance P (SP) is thought to play a crucial role in the traumatic brain injury (TBI). Calcitonin gene‐related peptide (CGRP) is an inflammatory neuropeptide found in neurons. The purpose of research is to explore the correlation between SP and CGRP in the rats plasma after TBI and to study their significance in the neuropathic mechanism of TBI.Methodsl68 male Wistar rats were randomized into the injury group and control group.Mild,moderate and severe injury models (0.5‐1.0 atm,1.5‐2.0 atm and 2.5‐3.0atm ) was produced with the fluid percussion brain injury (FPI) technique in anesthetized adult rats equipped with a closed cranial window.All groups were again stratified into 7 sub‐groups according to the time after TBI(0.5,2,6,12,24,48 and 72 h).The plasma levels of SP and CGRP were measured with ELISA at specific time after the injury.ResultsThere was a positive correlation between the plasma levels of SP and CGRP (r=0.879.P<0.01)after TBI.The plasma levels of SP and CGRP varied significantly across all groups with different severity of TBI(P<0.01) and time after injury (P<0.01).The peak and trough of plasma levels of SP were recorded in 0.5 h‐moderate (1.46±0.23ng)and 24h‐severe (0.43±0.17ng) sub‐groups,and those of CGRP were recorded in 2 h‐moderate (5.9±0.9ng)and 24 h‐severe sub‐groups(0.7±0.4ng) respectively.ConclusionThese data show that both plasma levels of SP and CGRP changed regularly with the severity of injury and the time after TBI. A positive correlation also be observed between the plasma levels of SP and CGRP.Therefore, detection of plasma SP and CGRP should be helpful to estimate the severity of injury and pathological changes of the TBI.
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.